Shree Pacetronix Ltd
BSE:527005
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its Industry Average (36.6), the stock would be worth ₹207.41 (40% upside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 26.1 | ₹147.95 |
0%
|
| Industry Average | 36.6 | ₹207.41 |
+40%
|
| Country Average | 23.4 | ₹132.68 |
-10%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
S
|
Shree Pacetronix Ltd
BSE:527005
|
532.5m INR | 26.1 | 21.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170B USD | 54.1 | 59.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
160.6B USD | 16.9 | 25.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
126.1B USD | 27.2 | 38.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
107.5B USD | 17.4 | 23.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
97.4B USD | 23.6 | 33.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.6B EUR | 15.8 | 19.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.3B USD | 26.5 | 43.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.7B USD | 38.1 | 42.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.1B USD | 17.7 | 25.1 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
31.9B USD | 18.6 | 15.3 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 14.7 |
| Median | 23.4 |
| 70th Percentile | 39.6 |
| Max | 28 676 |
Other Multiples
Shree Pacetronix Ltd
Glance View
Shree Pacetronix Ltd. manufactures implantable cardiac pacemakers. The company is headquartered in Dhar, Madhya Pradesh. The firm operates through the life saving devices segment. Its geographical segments are India and Rest of the world. Its product offerings include pacemakers, pacing leads and pacing system analyzer. Its multi programmable pacemakers include Ventralite 940 +/ Tiranga, Pinnacle 8820 and Tiranga 302. Its rate responsive pacemakers include Charak DDDR and Pinnacle-R SSIR + Model 297. Its bivent pacemaker includes the Trinity R. Its external pacemaker includes Indus I SSB and Zeus-1. Its programmer for pacemaker includes Smart-E. Its pacing leads include temporary leads, introducer, Screw-in lead P12 Model 3844 VB, IS1 Bipolar Lead 3851 VB and Atrial J Bipolar Lead 3851 VB. The firm's subsidiary is Shree Coratomic Limited.
